AXQ Capital LP Acquires 2,166 Shares of Humana Inc. $HUM

AXQ Capital LP lifted its holdings in Humana Inc. (NYSE:HUM) by 98.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,365 shares of the insurance provider’s stock after acquiring an additional 2,166 shares during the period. AXQ Capital LP’s holdings in Humana were worth $1,067,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in HUM. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Humana by 16.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock worth $300,728,000 after purchasing an additional 158,528 shares during the period. Focus Partners Wealth increased its stake in Humana by 104.2% in the 1st quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock worth $1,701,000 after buying an additional 3,281 shares during the period. Circle Wealth Management LLC bought a new stake in shares of Humana during the first quarter valued at approximately $425,000. Kera Capital Partners Inc. bought a new stake in Humana during the 2nd quarter valued at $253,000. Finally, Voya Investment Management LLC lifted its stake in Humana by 7.7% in the first quarter. Voya Investment Management LLC now owns 45,190 shares of the insurance provider’s stock worth $11,957,000 after acquiring an additional 3,221 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Trading Up 1.6%

Shares of NYSE:HUM opened at $226.78 on Friday. The business’s 50-day moving average is $265.77 and its 200 day moving average is $257.04. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The firm has a market capitalization of $27.28 billion, a P/E ratio of 17.40, a P/E/G ratio of 1.71 and a beta of 0.42.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The business had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company’s revenue was up 11.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.16 earnings per share. On average, research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.6%. Humana’s dividend payout ratio (DPR) is currently 33.18%.

Analysts Set New Price Targets

Several brokerages recently issued reports on HUM. Morgan Stanley cut their price objective on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating on the stock in a report on Thursday, July 31st. Robert W. Baird cut their price target on Humana from $300.00 to $297.00 and set a “neutral” rating on the stock in a report on Friday, July 25th. Wall Street Zen cut Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research report on Friday, October 3rd. Finally, Bank of America boosted their target price on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $297.67.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.